|
KIF3A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.293760E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.226050E-02 |
| Normal-vs-Stage2 |
3.435800E-01 |
| Normal-vs-Stage3 |
1.403010E-01 |
| Normal-vs-Stage4 |
7.905800E-01 |
| Stage1-vs-Stage2 |
6.333400E-01 |
| Stage1-vs-Stage3 |
7.236000E-01 |
| Stage1-vs-Stage4 |
4.027000E-01 |
| Stage2-vs-Stage3 |
8.846200E-01 |
| Stage2-vs-Stage4 |
7.320000E-01 |
| Stage3-vs-Stage4 |
5.941200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.737100E-03 |
| Normal-vs-AfricanAmerican |
9.970400E-02 |
| Normal-vs-Asian |
9.776600E-01 |
| Caucasian-vs-AfricanAmerican |
5.866400E-01 |
| Caucasian-vs-Asian |
3.381200E-01 |
| AfricanAmerican-vs-Asian |
4.878600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.780700E-03 |
| Normal-vs-Female |
8.691000E-01 |
| Male-vs-Female |
4.000800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.111500E-02 |
| Normal-vs-Extreme_Weight |
5.098800E-03 |
| Normal-vs-Obese |
1.285620E-01 |
| Normal-vs-Extreme_Obese |
2.163800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.345000E-01 |
| Normal_Weight-vs-Obese |
6.895800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.494000E-01 |
| Extreme_Weight-vs-Obese |
1.072440E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.057200E-01 |
| Obese-vs-Extreme_Obese |
8.577800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.484000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.777600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.160400E-04 |
| Normal-vs-Age(81-100Yrs) |
9.442800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.189400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.369700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.914300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.942000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.142600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.564800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.360400E-02 |
| Normal-VS-Type2 PRCC |
2.191500E-02 |
| Normal-VS-KIRP CIMP |
1.021970E-01 |
| Normal-VS-Unclassified PRCC |
5.582400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.542400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.080800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.859390E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.769600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.215200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.615800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.595700E-04 |
| Normal-vs-N1 |
8.743600E-01 |
| Normal-vs-N2 |
9.092100E-02 |
| N0-vs-N1 |
4.135700E-02 |
| N0-vs-N2 |
8.680400E-01 |
| N1-vs-N2 |
3.161000E-01 |
|
|
